ID29226A - Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis - Google Patents
Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesisInfo
- Publication number
- ID29226A ID29226A IDW20010746A ID20010746A ID29226A ID 29226 A ID29226 A ID 29226A ID W20010746 A IDW20010746 A ID W20010746A ID 20010746 A ID20010746 A ID 20010746A ID 29226 A ID29226 A ID 29226A
- Authority
- ID
- Indonesia
- Prior art keywords
- cycopeptide
- farma
- objector
- angiogenesis
- size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19842415A DE19842415A1 (de) | 1998-09-16 | 1998-09-16 | Pharmazeutische Zubereitung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID29226A true ID29226A (id) | 2001-08-16 |
Family
ID=7881169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20010746A ID29226A (id) | 1998-09-16 | 1999-09-09 | Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6683051B1 (fr) |
| EP (2) | EP1466615B1 (fr) |
| JP (2) | JP2002524526A (fr) |
| KR (1) | KR100703253B1 (fr) |
| CN (2) | CN100352494C (fr) |
| AR (2) | AR022382A1 (fr) |
| AT (2) | ATE292470T1 (fr) |
| AU (1) | AU765073B2 (fr) |
| BR (1) | BR9913737A (fr) |
| CA (1) | CA2344151A1 (fr) |
| CO (1) | CO5140070A1 (fr) |
| CZ (1) | CZ302908B6 (fr) |
| DE (3) | DE19842415A1 (fr) |
| DK (2) | DK1113809T3 (fr) |
| ES (2) | ES2327331T3 (fr) |
| HU (1) | HUP0103521A3 (fr) |
| ID (1) | ID29226A (fr) |
| IL (2) | IL141516A0 (fr) |
| MY (1) | MY129572A (fr) |
| NO (1) | NO331734B1 (fr) |
| NZ (1) | NZ510040A (fr) |
| PE (1) | PE20001046A1 (fr) |
| PL (1) | PL201902B1 (fr) |
| PT (2) | PT1113809E (fr) |
| RU (1) | RU2227041C2 (fr) |
| SI (1) | SI1113809T1 (fr) |
| SK (1) | SK287012B6 (fr) |
| TR (1) | TR200100765T2 (fr) |
| TW (1) | TW576744B (fr) |
| WO (1) | WO2000015244A2 (fr) |
| ZA (1) | ZA200103073B (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
| BR0116575A (pt) * | 2001-01-09 | 2004-01-06 | Merck Patent Gmbh | Terapia combinada que usa inibidores de tirosina cinase receptora e inibidores de angiogênese |
| JP4542783B2 (ja) * | 2002-03-05 | 2010-09-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有複素環化合物及び血管新生抑制剤とを組み合わせてなる抗腫瘍剤 |
| ES2671522T3 (es) | 2004-04-02 | 2018-06-06 | The Regents Of The University Of California | Métodos y composiciones para tratar y prevenir una enfermedad asociada con la integrina alfa V beta 5 |
| BRPI0618050A2 (pt) * | 2005-11-02 | 2011-08-16 | Univ Duke | uso de peptìdeo egfrviii e vacina antitumor em combinação com outros componentes para o tratamento de tumor |
| US20090130098A1 (en) * | 2006-01-18 | 2009-05-21 | Merck Patent Gmbh | Specific therapy using integrin ligands for treating cancer |
| US20110165150A1 (en) * | 2006-01-18 | 2011-07-07 | Merck Patent Gmbh | Isolated organ perfusion combination therapy of cancer |
| CA2675813A1 (fr) | 2007-01-18 | 2008-07-24 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Therapie specifique et medicament utilisant des ligands d'integrine ou traitant le cancer |
| CA2693863C (fr) | 2007-07-17 | 2017-10-03 | Merck Patent Gmbh | Anticorps hybrides modifies diriges contre l'integrine alpha v |
| WO2010051667A1 (fr) * | 2008-11-10 | 2010-05-14 | 复旦大学 | Compositions pharmaceutiques comprenant des nanotubes de peptide cyclique et utilisations de celles-ci |
| WO2010057596A2 (fr) * | 2008-11-20 | 2010-05-27 | Merck Patent Gmbh | Nouvelle thérapie et médicament utilisant des ligands d'intégrine pour traiter un cancer |
| AU2010252280A1 (en) | 2009-05-25 | 2012-01-19 | Merck Patent Gmbh | Continuous administration of cilengitide in cancer treatments |
| IN2012DN00303A (fr) | 2009-07-24 | 2015-05-08 | Univ California | |
| EA022700B1 (ru) | 2009-12-10 | 2016-02-29 | Мерк Патент Гмбх | Фармацевтическая композиция, содержащая олигопептиды |
| EP2593122A1 (fr) | 2010-07-16 | 2013-05-22 | Merck Patent GmbH | Peptide pour une utilisation dans le traitement du cancer du sein et/ou de métastases osseuses |
| WO2012069149A1 (fr) | 2010-11-23 | 2012-05-31 | Merck Patent Gmbh | Solution contenant des oligopeptides cycliques |
| KR101972533B1 (ko) | 2011-02-11 | 2019-08-26 | 메르크 파텐트 게엠베하 | 전립선암 치료용 항-알파-ｖ 인테그린 항체 |
| WO2012110200A1 (fr) * | 2011-02-18 | 2012-08-23 | Merck Patent Gmbh | Peptide cyclique, cyclo-(l‑arginyl-glycyl-l‑aspartyl-d‑phénylalanyl- n‑méthyl-l‑valyle), compositions associées et utilisation dans des méthodes de traitement de la maladie du greffon contre l'hôte |
| CN103717205B (zh) * | 2011-06-09 | 2017-04-12 | 默克专利股份公司 | 用西仑吉肽在载体中的悬浮液治疗癌症和癌症转移 |
| US20130230485A1 (en) * | 2012-03-01 | 2013-09-05 | Kathleen E. Rodgers | Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy |
| CN103333227B (zh) * | 2013-06-07 | 2015-10-07 | 东南大学 | 转移肿瘤缺失蛋白小分子环肽抑制剂及其制备方法与应用 |
| US20190242908A1 (en) | 2016-09-08 | 2019-08-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating nephrotic syndrome |
| JP2019208422A (ja) * | 2018-06-04 | 2019-12-12 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途 |
| GB201911816D0 (en) * | 2019-08-16 | 2019-10-02 | Univ London Queen Mary | Treatment |
| GB202103122D0 (en) * | 2021-03-05 | 2021-04-21 | Univ London Queen Mary | Treatment |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04367367A (ja) | 1991-06-11 | 1992-12-18 | Nkk Corp | ロータリノズル |
| AU674553B2 (en) | 1992-10-14 | 1997-01-02 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| AU675689B2 (en) | 1992-12-01 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| DE69528829T2 (de) | 1994-05-27 | 2003-08-07 | Merck & Co Inc | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption |
| JPH10504807A (ja) | 1994-06-29 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体拮抗剤 |
| HUT76344A (en) | 1994-06-29 | 1997-08-28 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| DK0710657T3 (da) | 1994-11-02 | 1999-05-25 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
| DE19534177A1 (de) * | 1995-09-15 | 1997-03-20 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| DE19548709A1 (de) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| JPH09208571A (ja) * | 1996-02-02 | 1997-08-12 | Takeda Chem Ind Ltd | アルキリデンシクロヘキサン誘導体 |
| WO1997041844A1 (fr) | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Combinaisons de composes angiostatiques |
| US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
| CZ380098A3 (cs) | 1996-05-31 | 1999-05-12 | The Scripps Research Institute | Způsoby, výrobky, farmaceutické látky a alfa v beta5 antagonisté, vhodní pro inhibici angiogeneze řízené alfa v beta5 |
| JPH1081631A (ja) * | 1996-07-17 | 1998-03-31 | Takeda Chem Ind Ltd | 癌転移または再発抑制剤 |
| DE19629817A1 (de) | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| DE19629816A1 (de) | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| UA60311C2 (uk) | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
| JP2001509176A (ja) * | 1997-01-17 | 2001-07-10 | メルク エンド カンパニー インコーポレーテッド | インテグリンアンタゴニスト |
| DE19850131A1 (de) | 1998-10-30 | 2000-05-04 | Merck Patent Gmbh | Chromenon- und Chromanonderivate |
-
1998
- 1998-09-16 DE DE19842415A patent/DE19842415A1/de not_active Withdrawn
-
1999
- 1999-09-09 EP EP04006076A patent/EP1466615B1/fr not_active Expired - Lifetime
- 1999-09-09 PL PL348026A patent/PL201902B1/pl not_active IP Right Cessation
- 1999-09-09 ID IDW20010746A patent/ID29226A/id unknown
- 1999-09-09 AT AT99969031T patent/ATE292470T1/de active
- 1999-09-09 CA CA002344151A patent/CA2344151A1/fr not_active Abandoned
- 1999-09-09 ES ES04006076T patent/ES2327331T3/es not_active Expired - Lifetime
- 1999-09-09 AT AT04006076T patent/ATE432707T1/de active
- 1999-09-09 JP JP2000569828A patent/JP2002524526A/ja active Pending
- 1999-09-09 PT PT99969031T patent/PT1113809E/pt unknown
- 1999-09-09 KR KR1020017003238A patent/KR100703253B1/ko not_active IP Right Cessation
- 1999-09-09 US US09/787,374 patent/US6683051B1/en not_active Expired - Lifetime
- 1999-09-09 DK DK99969031T patent/DK1113809T3/da active
- 1999-09-09 CN CNB2004100834955A patent/CN100352494C/zh not_active Expired - Fee Related
- 1999-09-09 NZ NZ510040A patent/NZ510040A/en not_active IP Right Cessation
- 1999-09-09 DK DK04006076T patent/DK1466615T3/da active
- 1999-09-09 SI SI9930792T patent/SI1113809T1/xx unknown
- 1999-09-09 HU HU0103521A patent/HUP0103521A3/hu unknown
- 1999-09-09 PT PT04006076T patent/PT1466615E/pt unknown
- 1999-09-09 AU AU59758/99A patent/AU765073B2/en not_active Ceased
- 1999-09-09 DE DE59911881T patent/DE59911881D1/de not_active Expired - Lifetime
- 1999-09-09 EP EP99969031A patent/EP1113809B1/fr not_active Expired - Lifetime
- 1999-09-09 ES ES99969031T patent/ES2241363T3/es not_active Expired - Lifetime
- 1999-09-09 WO PCT/EP1999/006654 patent/WO2000015244A2/fr active IP Right Grant
- 1999-09-09 SK SK337-2001A patent/SK287012B6/sk not_active IP Right Cessation
- 1999-09-09 DE DE59915033T patent/DE59915033D1/de not_active Expired - Lifetime
- 1999-09-09 CN CNB998133876A patent/CN1201812C/zh not_active Expired - Fee Related
- 1999-09-09 CZ CZ20010932A patent/CZ302908B6/cs not_active IP Right Cessation
- 1999-09-09 TR TR2001/00765T patent/TR200100765T2/xx unknown
- 1999-09-09 RU RU2001110104/15A patent/RU2227041C2/ru not_active IP Right Cessation
- 1999-09-09 BR BR9913737-2A patent/BR9913737A/pt not_active Application Discontinuation
- 1999-09-09 IL IL14151699A patent/IL141516A0/xx unknown
- 1999-09-13 PE PE1999000926A patent/PE20001046A1/es not_active Application Discontinuation
- 1999-09-13 MY MYPI99003955A patent/MY129572A/en unknown
- 1999-09-15 AR ARP990104617A patent/AR022382A1/es not_active Application Discontinuation
- 1999-09-16 CO CO99058733A patent/CO5140070A1/es unknown
- 1999-09-16 TW TW088116003A patent/TW576744B/zh not_active IP Right Cessation
-
2001
- 2001-02-19 IL IL141516A patent/IL141516A/en not_active IP Right Cessation
- 2001-03-15 NO NO20011308A patent/NO331734B1/no not_active IP Right Cessation
- 2001-04-12 ZA ZA200103073A patent/ZA200103073B/en unknown
-
2010
- 2010-09-15 AR ARP100103356A patent/AR078175A2/es not_active Application Discontinuation
-
2011
- 2011-08-12 JP JP2011176480A patent/JP2011252012A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID29226A (id) | Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis | |
| DE69811357T2 (de) | Brausezusammensetzungen sowie trockene brausegranulate | |
| NO954276L (no) | Surgjöring av underjordiske reservoarer | |
| HUP9902000A3 (en) | Combination of materials for the low temperature triggering of the activation of getter materials and getter devices containing the same | |
| NO981099L (no) | Vannbaserte sammensetninger for tetning av underjordiske soner samt fremgangsmÕter | |
| ID20586A (id) | Skeloroglukan baru dan komposisi kosmetik yang mengandung senyawa baru | |
| MX220980B (en) | Cementing compositions and use of such compositions for cementing oil wells or the like | |
| DE69806914T2 (de) | Agentimplementierte verriegelungsvorrichtung | |
| MXPA01006099A (es) | Metodos y composiciones para reducir las permeabilidades de zonas subterraneas. | |
| HUP9900812A3 (en) | Thermally stabilized contrast agent | |
| ID16856A (id) | Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan | |
| ID26945A (id) | Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan | |
| ID26402A (id) | Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya | |
| ID16517A (id) | Metode dan peralatan sumur untuk kerikil yang membungkus sumur yang menggunakan cairan kepekatan rendah | |
| PL334517A1 (en) | Clavulate and one or more of exicipients containing granules | |
| ID28382A (id) | Bahan anti keringat dan komposisi-komposisi yang mengandung bahan anti keringat | |
| EE200100061A (et) | Migreeni kordumise ärahoimine | |
| ID28640A (id) | Serbuk magnit dan magnit yang diikat isotrop | |
| HUP0003587A3 (en) | Protective relay and modul performing one or more functions of its | |
| HUP9900476A3 (en) | Blockbrick for building of drywall, and made of blockbrick drywall | |
| DE69510979D1 (de) | Kompositpulver aus Siliciumnitrid und Siliciumcarbid | |
| ID21840A (id) | Turunan-turunan oksopiperazinil dan komposisi-komposisi yang distabilkan terhadap cahaya | |
| NO984307D0 (no) | Anvendelsen av spesielle tilberedninger som avskummere | |
| ZA200104825B (en) | CVD Titanium-Boron and Chromium-Boron Coating of Diamond. | |
| EP1044937A4 (fr) | Machefer de ciment et ciment le contenant |